PodcastOne, Inc. (NASDAQ:PODC – Get Free Report) Director D Jonathan Merriman bought 14,000 shares of the business’s stock in a transaction dated Friday, September 20th. The shares were bought at an average cost of $1.89 per share, for a total transaction of $26,460.00. Following the purchase, the director now directly owns 179,339 shares in the company, valued at approximately $338,950.71. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
D Jonathan Merriman also recently made the following trade(s):
- On Wednesday, September 11th, D Jonathan Merriman purchased 17,800 shares of PodcastOne stock. The shares were acquired at an average cost of $1.71 per share, with a total value of $30,438.00.
- On Monday, September 9th, D Jonathan Merriman bought 10,000 shares of PodcastOne stock. The stock was purchased at an average cost of $1.60 per share, with a total value of $16,000.00.
- On Tuesday, July 16th, D Jonathan Merriman bought 28,000 shares of PodcastOne stock. The shares were acquired at an average price of $1.56 per share, with a total value of $43,680.00.
PodcastOne Trading Down 11.0 %
PODC stock opened at $1.62 on Wednesday. The company has a fifty day simple moving average of $1.53 and a two-hundred day simple moving average of $1.77. PodcastOne, Inc. has a 52 week low of $1.20 and a 52 week high of $3.68.
Wall Street Analysts Forecast Growth
Separately, Litchfield Hills Research assumed coverage on shares of PodcastOne in a research note on Thursday, June 6th. They issued a “buy” rating and a $5.00 price objective for the company.
Check Out Our Latest Stock Report on PodcastOne
PodcastOne Company Profile
PodcastOne, Inc operates as a podcast platform and publisher. The company offers its content to audiences through podcasting distribution platforms, including its website, Apple Podcasts, Spotify, Amazon Music, and others. It also produces vodcasts, branded podcasts, merchandise, and live events. In addition, the company builds, owns, and operates LaunchPadOne, a self-publishing podcast platform.
Read More
- Five stocks we like better than PodcastOne
- What is Insider Trading? What You Can Learn from Insider Trading
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- What is a SEC Filing?
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for PodcastOne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PodcastOne and related companies with MarketBeat.com's FREE daily email newsletter.